Option Care stock surges on McKesson's home-infusion bet
Option Care Health (OPCH) shares rose 33% to $31.11 after McKesson (MCK) and Clayton, Dubilier & Rice agreed to take it private for $32.05 per share, valuing it at $5.8B. McKesson will initially own 49%, with an option to acquire the rest later. The deal gives McKesson access to Option Care's home-infusion network, serving 315K+ patients. Option Care's Q2 revenue grew 1.9% to $1.44B. The deal needs shareholder and regulatory approvals to close in early 2027.
How this was made
The 30-second read
Why it matters
The deal creates a strategic foothold for McKesson in home infusion and may drive sector consolidation.
Market read
A large‑scale M&A in the healthcare sector with immediate price impact and long‑term strategic implications.
What to watch
Regulatory approval risk and potential future acquisition cost for McKesson.
Background
The article reports the first public disclosure of the Option Care acquisition by McKesson and CD&R.
Ticker impact
Option Care announced a $5.8B cash acquisition, causing its shares to surge 33% before delisting.
likely pressure as the market prices in the cash premium and eventual delisting.
The deal is newly disclosed, premium is sizable, and the stock will be taken private.
McKesson disclosed a $1.4B minority stake purchase in Option Care, expanding its home‑infusion network.
potential modest upside as investors value the new network exposure.
The transaction is newly announced and adds a new revenue channel for McKesson.
Market effects
Strengthens the specialty‑care and home‑infusion sector, signaling consolidation.
U.S. healthcare services market sees increased M&A activity.
Highlights trend of shifting complex therapies to outpatient settings worldwide.
Counterpoint
The premium may be excessive if integration costs rise, suggesting caution.
Key entities
- CompanyOption Care Health
Home‑infusion provider being taken private.
- CompanyMcKesson Corporation
Pharmaceutical distributor acquiring a minority stake.
- Private EquityClayton, Dubilier & Rice
Acquires majority ownership of Option Care.
